References
1. D’Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic
Surgeons adult cardiac surgery database: 2017 update on outcomes and
quality. Ann Thorac Surg 2017;103:18-24.
2. Gammie JS, Zhao Y, Peterson ED, O’Brien SM, Rankin JS, Griffith BP.
Less-invasive mitral valve operations: trends and outcomes from The
Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac
Surg. 2010;90: 1401-10.
3. Smit Y, Vlayen J, Koppenaal H, et al. Percutaneous coronary
invervention versus coronary artery bypass grafting: a meta-analysis. J
Thorac Cardiovasc Surg 2015;149:831-8.e1-13.
4. Park SJ, Ahn JM, Kim YH, et al. Trial of everolimuseluting stents or
bypass surgery for coronary disease. N Engl J Med 2015;372:1204-12.
5. Sipahi I, Akay MH, Dagdelen S, et al. Coronary artery bypass grafting
versus percutaneous coronary intervention and long-term mortality and
morbidity in multivessel disease: Meta-analysis of randomized clinical
trials of the arterial grafting and stenting era. JAMA Intern Med
2014;174:223-30.
6. Hannan EL, Zhong Y, Walford G, et al. Coronary artery bypass graft
surgery versus drug-eluting stents for patients with isolated proximal
left anterior descending disease. J Am Coll Cardiol 2014;64:2717-26.
7. Hayward PA, Buxton BF. Contemporary coronary graft patency: 5-year
observational data from a randomized trial of conduits. Ann Thorac Surg
2007;84:795-9.
8. Byrne JG, Leacche M, Vaughan DE, Zhao DX, Hybrid cardiovascular
procedures, JACC Cardiovasc Interv, 2008;1(5):459–68.
9. Umakanthan R, Leacche M, Zhao DX, et al., Hybrid options for treating
cardiac disease, Semin Thorac Cardiovasc Surg, 2011;23(4):274–80.
10. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy
C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz
RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard
stents in patients with stenosis in a native coronary artery. N Engl J
Med. 2003;349:1315–1323.
11. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for
atrial fibrillation after cardiac surgery. JAMA2004;291:1720-29.
12. Moscarelli M, Fattouch K, Casula R, et al. What is the role of
minimally invasive mitral valve surgery in highrisk patients? A
meta-analysis of observational studies. Ann Thorac Surg 2016;101:981-89.
13. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality,
postoperative morbidity, and cost after red blood cell transfusion in
patients having cardiac surgery. Circulation 2007;116:2544-52.
14. Kumar AB, Suneja M, Bayman EO, et al. Association between
postoperative acute kidney injury and duration of cardiopulmonary
bypass: a meta-analysis. J Cardiothorac Vasc Anesth 2012;26:64-9.
15. Cruden NL, Morch K, Wong DR, Klinke WP, Ofiesh J, Hilton JD.
Clopidogrel loading dose and bleeding outcomes in patients undergoing
urgent coronary artery bypass grafting. Am Heart J 2011;161:404–10.
16. Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, et al.
Staged initial percutaneous coronary intervention followed by valve
surgery (“hybrid approach”) for patients with complex coronary and
valve disease. J Am Coll Cardiol. 2005;45:14-8.
17. Brinster DR, Byrne M, Rogers CD, Baim DS, Simon DI, Couper GS, et
al. Effectiveness of same day percutaneous coronary intervention
followed by minimally invasive aortic valve replacement for aortic
stenosis and moderate coronary disease (“hybrid approach”). Am J
Cardiol. 2006;98:1501-3.
18. Santana O, Pineda AM, Cortes-Bergoderi M, et al. Hybrid approach of
percutaneous coronary intervention followed by minimally invasive valve
operations. Ann Thorac Surg 2014;97:2049-55.
19. Mihos CG, Xydas S, Williams RF, Pineda AM, Yucel E, Davila H, Beohar
N, Santana O. Staged percutaneous coronary intervention followed by
minimally invasive mitral valve surgery versus combined coronary artery
bypass graft and mitral valve surgery for two-vessel coronary artery
disease and moderate to severe ischemic mitral regurgitation. J Thorac
Dis 2017;9(Suppl 7):S563-S568. doi: 10.21037/jtd.2017.04.17.
20. Salis S, Mazzanti VV, Merli G, et al. Cardiopulmonary bypass
duration is an independent predictor of morbidity and mortality after
cardiac surgery. J Cardiothorac Vasc Anesth 2008;22:814-22.
21. George I, Nazif TM, Kalesan B, et al. Feasibility and early safety
of single-stage hybrid coronary intervention and valvular cardiac
surgery. Ann Thorac Surg 2015;99:2032-7.
22. Ranucci M, Ballotta A, Agnelli B, Frigiola A, Menicanti L,
Castelvecchio S; Surgical and Clinical Outcome Research (SCORE) Group.
Acute kidney injury in patients undergoing cardiac operation and
coronary angiography on the same day. Ann Thorac Surg 2013;95:513–9.
23. Kramer RS, Quinn RD, Groom RC, et al; Northern New England
Cardiovascular Disease Study Group. Same admission cardiac
catheterization and cardiac operation: is there an increased incidence
of acute kidney injury? Ann Thorac Surg 2010;90:1418–24.
24. Santana O, Funk M, Zamora C, et al. Staged percutaneous coronary
intervention and minimally invasive valve surgery: results of a hybrid
approach to concomitant coronary and valvular disease. J Thorac
Cardiovasc Surg 2012;144:634-9.
25. Umakanthan R, Leacche M, Petracek MR, et al., Combined PCI and
minimally invasive heart valve surgery for high-risk patients, Curr
Treat Options Cardiovasc Med, 2009;11(6):492–8.
26. Solenkova NV, Umakanthan R, Leacche M, et al., The new era of
cardiac surgery: hybrid therapy for cardiovascular disease, Innovations
(Phila), 2010;5(6):388–93.
27. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass
graft surgery versus percutaneous coronary intervention in patients with
three-vessel and/or left main coronary disease: 5-year follow-up of the
randomized, clinical SYNTAX trial. Lancet 2013;381:629–38.
28. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for
multivessel revascularization in patients with diabetes. N Engl J Med
2012;367:2375–84.
29. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to
coronary conduits of 15 years. Ann Thorac Surg 2004;77:93–101.
30. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary
restenosis for drug-eluting stent comparison. Circulation. 2005;111:
3435–3442.